Richard Daniell - Mar 4, 2022 Form 4 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Signature
/s/ Dov Bergwerk as attorney-in-fact for Richard Daniell
Stock symbol
TEVA
Transactions as of
Mar 4, 2022
Transactions value $
-$438,494
Form type
4
Date filed
3/8/2022, 03:03 PM
Previous filing
Mar 2, 2022
Next filing
Feb 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TEVA Ordinary Shares Options Exercise +15.9K +78.5% 36.2K Mar 4, 2022 Direct F1, F2
transaction TEVA Ordinary Shares Sale -$119K -15.9K -43.98% $7.48 20.3K Mar 4, 2022 Direct F1, F3, F4
transaction TEVA Ordinary Shares Options Exercise +43.4K +213.8% 63.6K Mar 4, 2022 Direct F1, F2
transaction TEVA Ordinary Shares Sale -$153K -20.5K -32.14% $7.48 43.2K Mar 4, 2022 Direct F1, F3, F4, F5
transaction TEVA Ordinary Shares Options Exercise +22.6K +52.28% 65.8K Mar 5, 2022 Direct F1, F2
transaction TEVA Ordinary Shares Sale -$166K -22.6K -34.33% $7.37 43.2K Mar 7, 2022 Direct F1, F3, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TEVA Restricted Share Units Options Exercise $0 -15.9K -50% $0.00 15.9K Mar 4, 2022 Ordinary Shares 15.9K Direct F1, F2, F7
transaction TEVA Restricted Share Units Options Exercise $0 -43.4K -100% $0.00* 0 Mar 4, 2022 Ordinary Shares 43.4K Direct F1, F2, F8
transaction TEVA Restricted Share Units Award $0 +134K $0.00 134K Mar 4, 2022 Ordinary Shares 134K Direct F1, F2, F9
transaction TEVA Restricted Share Units Options Exercise $0 -22.6K -25% $0.00 67.7K Mar 5, 2022 Ordinary Shares 22.6K Direct F1, F2, F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
F3 The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.40 to $7.60, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
F5 Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.30 to $7.49, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
F7 Restricted share units were granted on March 4, 2019, with 15,920 having vested on each of March 4, 2021 and March 4, 2022, and 15,921 vesting on March 4, 2023.
F8 Restricted share units were received on February 8, 2022 upon satisfaction of performance criteria and vested on March 4, 2022.
F9 Restricted share units were granted on March 4, 2022, with 33,512 vesting on each of March 4, 2023, March 4, 2024, March 4, 2025 and March 4, 2026.
F10 Restricted share units were granted on March 5, 2021, with 22,576 having vested on March 5, 2022 and 22,576 vesting on each of March 5, 2023, March 5, 2024 and March 5, 2025.